Timing and Duration of Myocardial Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention and Their Association With Clinical Outcomes (a PROTECT-TIMI 30 Substudy Analysis)

American Journal of Cardiology

Volumn 104, Issue 1, 2009, Pages 36-40

  Gibson, C Michael ^a   Pride, Yuri B ^b   Buros, Jacqueline L ^a   Ciaglo, Lauren N ^a   Morrow, David A ^c   Scirica, Benjamin M ^c   Stone, Peter H ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; HIRULOG; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY STENT; DISEASE DURATION; FEMALE; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOLTER MONITORING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; STENT THROMBOSIS; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONFIDENCE INTERVALS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TRUTH DISCLOSURE;

EID: 67649385761     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.044     Document Type: Article

References (19)

1. Gibson C.M., Morrow D.A., Murphy S.A., Palabrica T.M., Jennings L.K., Stone P.H., Lui H.H., Bulle T., Lakkis N., Kovach R., Cohen D.J., Fish P., McCabe C.H., and Braunwald E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. J Am Coll Cardiol 47 (2006) 2364-2373
2. Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., and Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
3. Gibson C.M., Cannon C.P., Murphy S.A., Marble S.J., Barron H.V., and Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105 (2002) 1909-1913
4. Gibson C.M., Cannon C.P., Murphy S.A., Ryan K.A., Mesley R., Marble S.J., McCabe C.H., Van De Werf F., and Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
5. Akkerhuis K.M., Klootwijk P.A., Lindeboom W., Umans V.A., Meij S., Kint P.P., and Simoons M.L. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. Eur Heart J 22 (2001) 1997-2006
6. Goodman S.G., Barr A., Sobtchouk A., Cohen M., Fromell G.J., Laperriere L., Hill C., and Langer A. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. J Am Coll Cardiol 36 (2000) 1507-1513
7. Gottlieb S.O., Weisfeldt M.L., Ouyang P., Mellits E.D., and Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 314 (1986) 1214-1219
8. Gottlieb S.O., Weisfeldt M.L., Ouyang P., Mellits E.D., and Gerstenblith G. Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 10 (1987) 756-760
9. Johnson S.M., Mauritson D.R., Winniford M.D., Willerson J.T., Firth B.G., Cary J.R., and Hillis L.D. Continuous electrocardiographic monitoring in patients with unstable angina pectoris: identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J 103 (1982) 4-12
10. Langer A., Freeman M.R., and Armstrong P.W. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 13 (1989) 1495-1502
11. Nademanee K., Intarachot V., Josephson M.A., Rieders D., Vaghaiwalla Mody F., and Singh B.N. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 10 (1987) 1-9
12. Patel D.J., Holdright D.R., Knight C.J., Mulcahy D., Thakrar B., Wright C., Sparrow J., Wicks M., Hubbard W., Thomas R., Sutton G.C., Hendry G., Purcell H., and Fox K. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 75 (1996) 222-228
13. Patel D.J., Knight C.J., Holdright D.R., Mulcahy D., Clarke D., Wright C., Purcell H., and Fox K.M. Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring. Eur Heart J 19 (1998) 240-249
14. Pozzati A., Bugiardini R., Borghi A., Ottani F., Muzi A., Morgagni G., and Puddu P. Transient ischaemia refractory to conventional medical treatment in unstable angina: angiographic correlates and prognostic implications. Eur Heart J 13 (1992) 360-365
15. Zairis M.N., Manousakis S.J., Adamopoulou E.N., Makrygiannis S.S., Glyptis M.P., Beldekos D.J., Patsourakos N.G., Olympios C.D., Prekates A.A., and Foussas S.G. Continuous 12-lead electrocardiographic ST monitoring and long-term prognosis after successful coronary stenting. Am Heart J 151 (2006) 892-897
16. Zairis M.N., Lyras A.G., Makrygiannis S.S., Beldekos D.J., Mainas K.A., Patsourakos N.G., Ampartzidou O.S., Adamopoulou E.N., Prekates A.A., Argyrakis S.K., and Foussas S.G. Continuous 12-lead electrocardiographic ST monitoring adds prognostic information to the thrombolysis in myocardial infarction risk score in patients with non-ST-elevation acute coronary syndromes. Clin Cardiol 28 (2005) 189-192
17. Cohen M.V., Yang X.M., and Downey J.M. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115 (2007) 1895-1903
18. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44 (2004) 1103-1110
19. Dumont E.A., Hofstra L., van Heerde W.L., van den Eijnde S., Doevendans P.A., DeMuinck E., Daemen M.A., Smits J.F., Frederik P., Wellens H.J., Daemen M.J., and Reutelingsperger C.P. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 102 (2000) 1564-1568